Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2018-03-07

Clinical Trial Update: Does Vitamin D Reduce Risk of Developing Type II DM in High Risk Individuals [Phase 3]

View source ↗

Summary

A Phase 3 trial testing whether vitamin D supplementation reduces the risk of developing Type 2 Diabetes Mellitus in high-risk individuals has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vitamin D (Cholecalciferol)

Snippet

Sponsor: King Faisal Specialist Hospital & Research Center | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: TERMINATED